|
[1] NOUREDDIN M, VIPANI A, BRESEE C, et al. NASH leading cause of liver transplant in women:Updated analysis of indications for liver transplant and ethnic and gender variances[J]. Am J Gastroenterol, 2018.[Epub ahead of print]
|
|
[2] CHITTURI S, FARRELL GC, HASHIMOTO E, et al. Non-alcoholic fatty liver disease in the Asia-Pacific region:Definitions and overview of proposed guidelines[J]. J Gastroenterol Hepatol, 2007, 22 (6) :778-787.
|
|
[3] WONG VW, CHAN WK, CHITTURI S, et al. Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines2017-Part 1:Definition, risk factors and assessment[J]. J Gastroenterol Hepatol, 2018, 33 (1) :70-85.
|
|
[4] YOUNOSSI ZM, KOENIG AB, ABDELATIF D, et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes[J]. Hepatology, 2016, 64 (1) :73-84.
|
|
[5] SETO WK, YUEN MF. Nonalcoholic fatty liver disease in Asia:Emerging perspectives[J]. J Gastroenterol, 2017, 52 (2) :164-174.
|
|
[6] PERUMPAIL BJ, KHAN MA, YOO ER, et al. Clinical epidemiology and disease burden of nonalcoholic fatty liver disease[J].World J Gastroenterol, 2017, 23 (47) :8263-8276.
|
|
[7] FARRELL GC, WONG VW, CHITTURI S. NAFLD in Asia-as common and important as in the West[J]. Nat Rev Gastroenterol Hepatol, 2013, 10 (5) :307-318.
|
|
[8] SINGH S, KUFTINEC GN, SARKAR S. Non-alcoholic fatty liver disease in South Asians:A review of the literature[J]. J Clin Transl Hepatol, 2017, 5 (1) :76-81.
|
|
[9] PATI GK, SINGH SP. Nonalcoholic fatty liver disease in South Asia[J]. Euroasian J Hepatogastroenterol, 2016, 6 (2) :154-162.
|
|
[10] KARIMI-SARI H, MOUSAVI-NAEINI SM, KHONCHE A.Comments on prevalence of non-alcoholic fatty liver disease and its related factors in Iran[J]. Int J Organ Transplant Med, 2017, 8 (1) :52-53.
|
|
[11] GOH SC, HO ELM, GOH KL. Prevalence and risk factors of nonalcoholic fatty liver disease in a multiracial suburban Asian population in Malaysia[J]. Hepatol Int, 2013, 7 (2) :548-554.
|
|
[12] JIE L, BIYAO Z, HIDEKI F, et al. Prevalence of non-alcoholic fatty liver disease (NAFLD) in Asia:A systematic review and meta-analysisof 195 studies and 1, 753, 168 subjects from 13 countries[C]. The 27th Asian Pacific Association for the Study of the Liver, 2018.
|
|
[13] FAN JG, KIM SU, WONG VW. New trends on obesity and NAFLD in Asia[J]. J Hepatol, 2017, 67 (4) :862-873.
|
|
[14] VANWAGNER LB, ARMSTRONG MJ. Lean NAFLD:A not so benign condition?[J]. Hepatol Commun, 2018, 2 (1) :5-8.
|
|
[15] FUNG J, LEE CK, CHAN M, et al. High prevalence of non-alcoholic fatty liver disease in the Chinese-results from the Hong Kong liver health census[J]. Liver Int, 2015, 35 (2) :542-549.
|
|
[16] LI Z, XUE J, CHEN P, et al. Prevalence of nonalcoholic fatty liver disease in mainland of China:A meta-analysis of published studies[J]. J Gastroenterol Hepatol, 2014, 29 (1) :42-51.
|
|
[17] ESTES C, ANSTEE QM, TERESA ARIAS-LOSTE M, et al.Modeling NAFLD disease Burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030[J]. J Hepatol, 2018, 69 (4) :896-904.
|
|
[18] YOUNOSSI Z, TACKE F, ARRESE M, et al. Global perspectives on non-alcoholic fatty liver disease and non-alcoholic steatohepatitis[J]. Hepatology, 2018.[Epub ahead of print]
|
|
[19] FAZEL Y, KOENIG AB, SAYINER M, et al. Epidemiology and natural history of non-alcoholic fatty liver disease[J]. Metabolism, 2016, 65 (8) :1017-1025.
|
|
[20] NIRIELLA MA, PATHMESWARAN A, DE SILVA ST, et al. Incidence and risk factors for non-alcoholic fatty liver disease:A 7-year follow-up study among urban, adult Sri Lankans[J]. Liver Int, 2017, 37 (11) :1715-1722.
|
|
[21] ZHANG T, ZHANG C, ZHANG Y, et al. Metabolic syndrome and its components as predictors of nonalcoholic fatty liver disease in a northern urban Han Chinese population:A prospective cohort study[J]. Atherosclerosis, 2015, 240 (1) :144-148.
|
|
[22] WU J, HE S, XU H, et al. Non-alcoholic fatty liver disease incidence, remission and risk factors among a general Chinese population with a 6-year follow-up[J]. Sci Rep, 2018, 8 (1) :7557.
|
|
[23] DICKSON I. NAFLD:Increased familial risk of fibrosis in NAFLD[J].Nat Rev Gastroenterol Hepatol, 2017, 14 (8) :450.
|
|
[24] NAKAHARA T, HYOGO H, YONEDA M, et al. Type 2 diabetes mellitus is associated with the fibrosis severity in patients with nonalcoholic fatty liver disease in a large retrospective cohort of Japanese patients[J]. J Gastroenterol, 2014, 49 (11) :1477-1484.
|
|
[25] MIYAKE T, KUMAGI T, HIROOKA M, et al. Significance of exercise in nonalcoholic fatty liver disease in men:A communitybased large cross-sectional study[J]. J Gastroenterol, 2015, 50 (2) :230-237.
|
|
[26] TAO Y, GU H, WU J, et al. Thyroid function is associated with non-alcoholic fatty liver disease in euthyroid subjects[J]. Endocr Res, 2015, 40 (2) :74-78.
|
|
[27] SHEN J, WONG GL, CHAN HL, et al. PNPLA3 gene polymorphism accounts for fatty liver in community subjects without metabolic syndrome[J]. Aliment Pharmacol Ther, 2014, 39 (5) :532-539.
|
|
[28] FRACANZANI AL, PETTA S, LOMBARDI R, et al. Liver and cardiovascular damage in patients with lean nonalcoholic fatty liver disease, and association with visceral obesity[J]. Clin Gastroenterol Hepatol, 2017, 15 (10) :1604-1611, e1601.
|
|
[29] MASARONE M, FEDERICO A, ABENAVOLI L, et al. Non alcoholic fatty liver:Epidemiology and natural history[J]. Rev Recent Clin Trials, 2014, 9 (3) :126-133.
|
|
[30] MARCUCCILLI M, CHONCHOL M. NAFLD and chronic kidney disease[J]. Int J Mol Sci, 2016, 17 (4) :562.
|
|
[31] SINN DH, KANG D, JANG HR, et al. Development of chronic kidney disease in patients with non-alcoholic fatty liver disease:A cohort study[J]. J Hepatol, 2017, 67 (6) :1274-1280.
|
|
[32] LEE DY, PARK JK, HUR KY, et al. Association between nonalcoholic fatty liver disease and bone mineral density in postmenopausal women[J]. Climacteric, 2018, 21 (5) :498-501.
|
|
[33] SHEN F, ZHENG RD, SHI JP, et al. Impact of skin capsular distance on the performance of controlled attenuation parameter in patients with chronic liver disease[J]. Liver Int, 2015, 35 (11) :2392-2400.
|
|
[34] FLORES A, MARRERO JA. Emerging trends in hepatocellular carcinoma:Focus on diagnosis and therapeutics[J]. Clin Med Insights Oncol, 2014, 8:71-76.
|
DownLoad: